Max Robotics — Global Service Robot Directory + US Certification

About

Xi-Tai Huang is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for complex hepatopancreatobiliary malignancies. His major contributions center on evaluating the safety, efficacy, and short-term outcomes of robotic-assisted radical resections for challenging conditions, including perihilar cholangiocarcinoma (pCCA) and pancreatic tumors. Through rigorous propensity-scored matching and inverse probability of treatment weighting analyses, Huang has demonstrated that robotic-assisted approaches can achieve comparable or superior results to traditional open surgeries, with potential benefits in reduced morbidity and faster recovery. His most cited work, "Evaluation of the short-term outcomes of robotic-assisted radical resection for perihilar cholangiocarcinoma" (17 citations), provides critical evidence for expanding robotic applications in this anatomically complex cancer. Huang has also reported on innovative procedures such as robotic-assisted hepatopancreatoduodenectomy for multiple endocrine neoplasia type 1, showcasing his technical expertise in managing rare, multi-hormone-secreting tumors. His comparative studies on robotic versus open hemi-hepatectomy and pancreatoduodenectomy continue to shape surgical decision-making, offering data-driven insights that help define the role of robotics in high-risk hepatobiliary surgery.